$SHWZ
Medicine Man Technologies, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022017270 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $40.15M $43.19M $26.52M
YoY Change 51.41% 35.67% 233.83%
Cost Of Revenue $17.18M $17.23M $14.37M
YoY Change 19.5% 2.66% 96.3%
Gross Profit $22.97M $25.96M $12.14M
YoY Change 89.18% 72.45% 1856.34%
Gross Profit Margin 57.22% 60.12% 45.79%
Selling, General & Admin $17.46M $6.726M $8.526M
YoY Change 104.84% -40.05% -9.72%
% of Gross Profit 76.03% 25.9% 70.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.683M $798.4K $797.0K
YoY Change 236.58% -73.14% 416.55%
% of Gross Profit 11.68% 3.07% 6.56%
Operating Expenses $17.46M $14.85M $8.526M
YoY Change 104.84% 32.36% -9.72%
Operating Profit $5.506M $11.11M $3.616M
YoY Change 52.27% 189.68% -140.99%
Interest Expense -$16.51M -$3.712M $11.61M
YoY Change -242.22% 146.58% -2023.88%
% of Operating Profit -299.92% -33.4% 321.11%
Other Income/Expense, Net $3.740K -$3.712M $0.00
YoY Change
Pretax Income -$23.70M $7.403M $15.23M
YoY Change -255.64% 224.46% -261.54%
Income Tax $3.639M $5.594M $2.398M
% Of Pretax Income 75.56% 15.75%
Net Earnings -$29.85M $1.809M $12.83M
YoY Change -332.64% 86.76% -250.45%
Net Earnings / Revenue -74.35% 4.19% 48.39%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.48 $0.00 $54.50K
COMMON SHARES
Basic Shares Outstanding 54.74M 54.45M shares
Diluted Shares Outstanding 138.0M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.40M $39.18M $106.4M
YoY Change -62.97% 85.07% 8541.71%
Cash & Equivalents $38.95M $38.73M $106.4M
Short-Term Investments $454.3K $451.2K
Other Short-Term Assets $5.293M $5.901M $3.038M
YoY Change 74.23% 128.81% 778.64%
Inventory $22.55M $21.29M $11.12M
Prepaid Expenses
Receivables $4.472M $5.176M $3.867M
Other Receivables $11.94K $47.78K $0.00
Total Short-Term Assets $71.74M $71.59M $123.9M
YoY Change -42.11% 88.61% 1966.11%
LONG-TERM ASSETS
Property, Plant & Equipment $27.09M $25.59M $10.25M
YoY Change 164.2% 105.86% 98.56%
Goodwill $94.61M $99.59M $43.32M
YoY Change 118.41% -18.34%
Intangibles $107.7M $111.1M $97.58M
YoY Change 10.4%
Long-Term Investments $2.000M $493.6K
YoY Change 305.23% 78.32%
Other Assets $1.527M $1.458M $515.0K
YoY Change 196.58% 225.32% 892.6%
Total Long-Term Assets $251.1M $258.0M $161.1M
YoY Change 55.88% 64.56% 149.08%
TOTAL ASSETS
Total Short-Term Assets $71.74M $71.59M $123.9M
Total Long-Term Assets $251.1M $258.0M $161.1M
Total Assets $322.9M $329.6M $285.0M
YoY Change 13.28% 69.25% 303.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.849M $5.757M $2.549M
YoY Change 207.92% 453.21% -28.35%
Accrued Expenses $10.31M $9.332M $5.592M
YoY Change 84.45% 50.09% 384.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $134.5K
YoY Change -100.0% -100.0% -97.31%
Long-Term Debt Due $2.250M $1.500M
YoY Change
Total Short-Term Liabilities $47.38M $30.04M $45.26M
YoY Change 4.68% 115.44% 266.2%
LONG-TERM LIABILITIES
Long-Term Debt $125.5M $122.9M $97.48M
YoY Change 28.76% 107.42% 601.22%
Other Long-Term Liabilities $17.31M $17.76M $8.715M
YoY Change 98.66% 366.55% 229.43%
Total Long-Term Liabilities $143.3M $140.7M $106.2M
YoY Change 34.97% 123.07% 541.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.38M $30.04M $45.26M
Total Long-Term Liabilities $143.3M $140.7M $106.2M
Total Liabilities $190.7M $170.7M $151.5M
YoY Change 25.92% 121.69% 423.95%
SHAREHOLDERS EQUITY
Retained Earnings -$46.24M -$18.90M -$27.77M
YoY Change 66.49%
Common Stock $56.35K $56.07K $45.49K
YoY Change 23.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.033M $1.991M $1.517M
YoY Change 34.02%
Treasury Stock Shares
Shareholders Equity $132.2M $158.9M $133.6M
YoY Change
Total Liabilities & Shareholders Equity $322.9M $329.6M $285.0M
YoY Change 13.28% 69.25% 303.25%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$29.85M $1.809M $12.83M
YoY Change -332.64% 86.76% -250.45%
Depreciation, Depletion And Amortization $2.683M $798.4K $797.0K
YoY Change 236.58% -73.14% 416.55%
Cash From Operating Activities $15.31M $4.005M $52.52M
YoY Change -70.84% 17.14% -1602.43%
INVESTING ACTIVITIES
Capital Expenditures $2.302M -$5.504M -$1.768M
YoY Change -230.16% 106.42% -948.09%
Acquisitions
YoY Change
Other Investing Activities $28.24M $3.297M -$3.751M
YoY Change -852.75% -156.41% -87.63%
Cash From Investing Activities $25.93M -$2.207M -$5.519M
YoY Change -569.86% -74.07% -81.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -41.02M 3.065M 38.24M
YoY Change -207.29% -40.26% 20.01%
NET CHANGE
Cash From Operating Activities 15.31M 4.005M 52.52M
Cash From Investing Activities 25.93M -2.207M -5.519M
Cash From Financing Activities -41.02M 3.065M 38.24M
Net Change In Cash 224.1K 4.863M 85.24M
YoY Change -99.74% 12686.64% -4978.91%
FREE CASH FLOW
Cash From Operating Activities $15.31M $4.005M $52.52M
Capital Expenditures $2.302M -$5.504M -$1.768M
Free Cash Flow $13.01M $9.509M $54.29M
YoY Change -76.03% 56.26% -1565.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
000-55450
dei Entity Registrant Name
EntityRegistrantName
MEDICINE MAN TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
dei Entity Central Index Key
EntityCentralIndexKey
0001622879
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5289499
dei Entity Address Address Line1
EntityAddressAddressLine1
4880 Havana Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80239
dei City Area Code
CityAreaCode
(303)
dei Local Phone Number
LocalPhoneNumber
371-0387
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54741506
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38725187
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106400216
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5176200
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3866828
CY2022Q3 us-gaap Inventory Net
InventoryNet
21289003
CY2021Q4 us-gaap Inventory Net
InventoryNet
11121997
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
47778
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
42353
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
216771
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
451200
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
493553
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5901058
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2523214
CY2022Q3 us-gaap Assets Current
AssetsCurrent
71590426
us-gaap Share Based Compensation
ShareBasedCompensation
3865588
CY2021Q4 us-gaap Assets Current
AssetsCurrent
124405808
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4011034
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1988973
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25592522
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10253226
CY2022Q3 us-gaap Goodwill
Goodwill
99592790
CY2021Q4 us-gaap Goodwill
Goodwill
43316267
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13960457
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7652750
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111073948
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
97582330
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
143333
CY2022Q3 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
290648
CY2021Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
303086
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1457646
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
514962
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19982940
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8511780
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
257990494
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
160624984
CY2022Q3 us-gaap Assets
Assets
329580920
CY2021Q4 us-gaap Assets
Assets
285030792
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5756736
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2548885
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
53819
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
36820
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9332382
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5592222
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6818053
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
34923013
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
134498
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2992540
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3588371
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2027741
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30041901
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45263179
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
122889447
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97482468
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17763177
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8715480
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
140652624
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
106197948
CY2022Q3 us-gaap Liabilities
Liabilities
170694525
CY2021Q4 us-gaap Liabilities
Liabilities
151461127
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6397157
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3644320
us-gaap Labor And Related Expense
LaborAndRelatedExpense
18934873
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8505733
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
99898
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
45485
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179723367
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162815097
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18902450
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
84304
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
82566
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56069212
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54741506
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45484314
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44745870
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
56069
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27773968
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
886459
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
517044
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1990678
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1517036
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
158886395
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
133569665
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
329580920
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285030792
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43190986
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31835305
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119231932
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81904261
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
17226451
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
16779313
us-gaap Cost Of Revenue
CostOfRevenue
57173192
us-gaap Cost Of Revenue
CostOfRevenue
44692765
CY2022Q3 us-gaap Gross Profit
GrossProfit
25964535
CY2021Q3 us-gaap Gross Profit
GrossProfit
15055992
us-gaap Gross Profit
GrossProfit
62058740
us-gaap Gross Profit
GrossProfit
37211496
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6725713
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5593336
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20245737
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13580469
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1626909
CY2021Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
752572
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
5729339
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
4466696
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1228764
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14849677
us-gaap Share Based Compensation
ShareBasedCompensation
1788823
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20400
CY2021Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-49985
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
242494
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
11218992
us-gaap Operating Expenses
OperatingExpenses
46698772
us-gaap Operating Expenses
OperatingExpenses
30418486
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11114858
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3837000
us-gaap Operating Income Loss
OperatingIncomeLoss
15359968
us-gaap Operating Income Loss
OperatingIncomeLoss
6793010
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8500235
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1851694
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23312088
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4526746
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
4816668
CY2021Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
356824
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
28104960
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
967751
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-28541
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-10572
us-gaap Gain Loss On Investments
GainLossOnInvestments
-42353
us-gaap Gain Loss On Investments
GainLossOnInvestments
210685
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3712108
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1555427
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4770919
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3105816
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5593513
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1312817
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11259369
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1997905
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1809237
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
968756
us-gaap Net Income Loss
NetIncomeLoss
8871518
us-gaap Net Income Loss
NetIncomeLoss
1689289
CY2022Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1784113
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
5294132
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25124
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
968756
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3577386
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1689289
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51232943
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44145709
shwz Return Of Common Stock As Compensation To Employee Officers And Or Directors
ReturnOfCommonStockAsCompensationToEmployeeOfficersAndOrDirectors
244007
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
762892
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50615437
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42903008
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137954532
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44145709
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137337027
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56688640
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
41774859
us-gaap Net Income Loss
NetIncomeLoss
1689289
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
25620000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
680862
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50449206
us-gaap Dividends
Dividends
5585020
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
184536
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3288435
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
117733095
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
133569665
us-gaap Net Income Loss
NetIncomeLoss
8871518
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15100058
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
473642
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
811897
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
158886395
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
111939679
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
968756
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5380000
CY2021Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1
CY2021Q3 us-gaap Dividends
Dividends
1784105
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1228764
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
117733095
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
156977187
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1809237
CY2022Q3 shwz Return Of Common Stock As Compensation To Employee Officers And Or Directors
ReturnOfCommonStockAsCompensationToEmployeeOfficersAndOrDirectors
-29
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
100000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
158886395
us-gaap Net Income Loss
NetIncomeLoss
8871518
us-gaap Net Income Loss
NetIncomeLoss
1689289
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8329767
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7779828
shwz Noncash Lease Expense
NoncashLeaseExpense
493782
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
28104960
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
967751
us-gaap Gain Loss On Investments
GainLossOnInvestments
-42353
us-gaap Gain Loss On Investments
GainLossOnInvestments
210685
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
292479
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1474380
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3865588
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1100055
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2179646
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2829157
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12511389
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3869658
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3034246
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2616732
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1964835
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
940184
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
396183
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
75295
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
114129
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
5127786
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-568387
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1560630
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1029482
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3957263
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4814104
us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
95555
us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
181911
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
92701905
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
71927071
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
29580
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105117739
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75644398
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
22473938
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
45344578
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
4433042
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4865502
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14492993
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50282797
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41399973
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
90761874
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-67675029
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19931580
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106400216
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1237236
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38725187
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21168816
us-gaap Interest Paid Net
InterestPaidNet
13239685
us-gaap Interest Paid Net
InterestPaidNet
3862970
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9840000
shwz Issuance Of Common Stock
IssuanceOfCommonStock
510525
shwz Return Of Common Stock
ReturnOfCommonStock
565501
shwz Issuance Of Stock As Payments For Acquisitions
IssuanceOfStockAsPaymentsForAcquisitions
9508872
CY2022Q1 shwz Number Of Dispensaries For Marijuana Production
NumberOfDispensariesForMarijuanaProduction
10
CY2022Q1 shwz Number Of Cultivating Facilities For Marijuana Production
NumberOfCultivatingFacilitiesForMarijuanaProduction
4
CY2022Q1 shwz Number Of Operating Facilities For Marijuana Production
NumberOfOperatingFacilitiesForMarijuanaProduction
3
CY2022Q1 shwz Number Of Work In Progress Facilities For Marijuana Production
NumberOfWorkInProgressFacilitiesForMarijuanaProduction
1
CY2022Q1 shwz Number Of Manufacturing Facilities For Marijuana Production
NumberOfManufacturingFacilitiesForMarijuanaProduction
1
CY2022Q1 shwz Area For Cultivation Facility
AreaForCultivationFacility
70000
CY2022Q1 shwz Area For Manufacturing Facility
AreaForManufacturingFacility
6000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29603556
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12242199
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4011034
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1988973
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25592522
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10253226
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
798354
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2022061
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
364399
us-gaap Depreciation And Amortization
DepreciationAndAmortization
818174
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
125034405
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13960457
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
105235080
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7652750
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2030012
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6307706
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2609987
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6961654
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8774887
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9842054
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9520667
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9412888
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8638056
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
8330329
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
56555067
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
111073948
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
48936674
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12676
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-14013661
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
34923013
CY2022Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
13417472
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
48340485
CY2022Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-36705764
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
11634721
CY2022Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-4816668
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
6818053
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1915403
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5505420
CY2021Q4 us-gaap Goodwill
Goodwill
43316267
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
55636522
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
640001
CY2022Q3 us-gaap Goodwill
Goodwill
99592790
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7295263
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5573329
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
10049172
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3944568
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5535992
CY2022Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7025206
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
8289743
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
42972369
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
48477789
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
124389447
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
97482468
CY2022Q3 shwz Less Current Portion Of Long Term Debt
LessCurrentPortionOfLongTermDebt
-1500000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
122889447
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97482468
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtIssuanceCostsRemainderOfFiscalYear
421512
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtDiscountRemainderOfFiscalYear
1979193
CY2022Q3 shwz Total Long Term Debt Remainder Of Fiscal Year
TotalLongTermDebtRemainderOfFiscalYear
-1979193
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2250000
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs Year One
LongTermDebtUnamortizedDebtIssuanceCostsYearOne
1686049
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount Year One
LongTermDebtUnamortizedDebtDiscountYearOne
8523493
CY2022Q3 shwz Total Long Term Debt Year One
TotalLongTermDebtYearOne
-6273493
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3000000
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs Year Two
LongTermDebtUnamortizedDebtIssuanceCostsYearTwo
1686049
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount Year Two
LongTermDebtUnamortizedDebtDiscountYearTwo
9734935
CY2022Q3 shwz Total Long Term Debt Year Two
TotalLongTermDebtYearTwo
-6734935
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
40651759
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs Year Three
LongTermDebtUnamortizedDebtIssuanceCostsYearThree
1686049
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount Year Three
LongTermDebtUnamortizedDebtDiscountYearThree
11057799
CY2022Q3 shwz Total Long Term Debt Year Three
TotalLongTermDebtYearThree
29593960
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
128485263
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs Year Four
LongTermDebtUnamortizedDebtIssuanceCostsYearFour
1545547
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount Year Four
LongTermDebtUnamortizedDebtDiscountYearFour
11676949
CY2022Q3 shwz Total Long Term Debt Year Four
TotalLongTermDebtYearFour
116808314
CY2022Q3 shwz Long Term Debt Maturities Repayments Of Principal
LongTermDebtMaturitiesRepaymentsOfPrincipal
174387022
CY2022Q3 shwz Long Term Debt Unamortized Debt Issuance Costs
LongTermDebtUnamortizedDebtIssuanceCosts
7025206
CY2022Q3 shwz Long Term Debt Unamortized Debt Discount
LongTermDebtUnamortizedDebtDiscount
42972369
CY2022Q3 shwz Total Long Term Debt
TotalLongTermDebt
131414653
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19982940
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2992540
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17763177
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
517044
CY2021Q4 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
221400
CY2022Q3 shwz Lessee Operating Lease Liability Payments Due Next Twelve Months1
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths1
34246054
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12143391
CY2022Q3 shwz Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
22102663
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1242307
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4646609
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5244672
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4653106
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4211405
CY2022Q3 shwz Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
14247955
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34246054
shwz Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q3 shwz Escrow Shares
EscrowShares
2690
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2021Q4 shwz Escrow Shares
EscrowShares
4428
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
1000
CY2022Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1.20
us-gaap Dividends Preferred Stock
DividendsPreferredStock
5294132
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1784113
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56069212
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54741506
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
886459
CY2022Q3 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
441247
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45484314
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44745870
CY2021Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
272
CY2021Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
245017
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2022Q3 us-gaap Revenues
Revenues
43190986
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17226451
CY2022Q3 shwz Gross Profit Amount
GrossProfitAmount
25964535
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2030012
CY2022Q3 us-gaap Depreciation
Depreciation
798355
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1809237
CY2022Q3 shwz Segment Assets
SegmentAssets
329580920
us-gaap Revenues
Revenues
119231932
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57173192
shwz Gross Profit Amount
GrossProfitAmount
62058740
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6307706
us-gaap Depreciation
Depreciation
2022061
us-gaap Net Income Loss
NetIncomeLoss
8871518.00
shwz Segment Assets
SegmentAssets
329580920
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2281573
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5593513
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1312817
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.7556
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.5754
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7402750
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20130887
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3687194
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11259369
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1997905
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.5593
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.5418
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1809237
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
968756
us-gaap Net Income Loss
NetIncomeLoss
8871518
us-gaap Net Income Loss
NetIncomeLoss
1689289
CY2022Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1784113
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
5294132
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25124
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
968756
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3577386
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1689289
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51232943
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44145709
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50615437
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42903008
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
25124
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
968756
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3577386
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1689289
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51232943
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44145709
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50615437
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42903008
shwz Dilutive Effect Of Warrants
DilutiveEffectOfWarrants
2229011
shwz Dilutive Effect Of Warrants
DilutiveEffectOfWarrants
4712670
CY2022Q3 shwz Dilutive Effect Of Options
DilutiveEffectOfOptions
1187124
CY2022Q3 shwz Dilutive Effect Of Warrants
DilutiveEffectOfWarrants
2229011
shwz Dilutive Effect Of Options
DilutiveEffectOfOptions
1187124
shwz Dilutive Effect Of Options
DilutiveEffectOfOptions
9072962
CY2022Q3 shwz Dilutive Effect Of Preferred Stock
DilutiveEffectOfPreferredStock
83305454
shwz Dilutive Effect Of Preferred Stock
DilutiveEffectOfPreferredStock
83305454
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137954532
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44145709
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137337027
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56688640
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03

Files In Submission

Name View Source Status
0001558370-22-017270-index-headers.html Edgar Link pending
0001558370-22-017270-index.html Edgar Link pending
0001558370-22-017270.txt Edgar Link pending
0001558370-22-017270-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220930.xsd Edgar Link pending
tmb-20220930x10q.htm Edgar Link pending
tmb-20220930xex10d10.htm Edgar Link pending
tmb-20220930xex10d11.htm Edgar Link pending
tmb-20220930xex10d2.htm Edgar Link pending
tmb-20220930xex10d3.htm Edgar Link pending
tmb-20220930xex10d4.htm Edgar Link pending
tmb-20220930xex10d5.htm Edgar Link pending
tmb-20220930xex10d6.htm Edgar Link pending
tmb-20220930xex10d7.htm Edgar Link pending
tmb-20220930xex10d7001.jpg Edgar Link pending
tmb-20220930xex10d7002.jpg Edgar Link pending
tmb-20220930xex10d8.htm Edgar Link pending
tmb-20220930xex10d9.htm Edgar Link pending
tmb-20220930xex2d1.htm Edgar Link pending
tmb-20220930xex2d2.htm Edgar Link pending
tmb-20220930xex31d1.htm Edgar Link pending
tmb-20220930xex31d2.htm Edgar Link pending
tmb-20220930xex32.htm Edgar Link pending
tmb-20220930_def.xml Edgar Link unprocessable
tmb-20220930_pre.xml Edgar Link unprocessable
tmb-20220930_lab.xml Edgar Link unprocessable
tmb-20220930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tmb-20220930_cal.xml Edgar Link unprocessable